Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD)

Clinical trial NCT07681778 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07681778
Sponsor: Opus Genetics, Inc
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leber Congenital Amaurosis Leber Congenital Amaurosis (LCA)

Start date: 2026-09-01
Primary completion: 2032-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.